Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference

Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) announced that Executive Vice President & Chief Financial Officer Sam Samad will discuss the company’s strategy, performance and market trends at the Morgan Stanley 24th Annual Global Healthcare Conference in New York City on Monday, September 14, 2026, at 10:00 a.m. Eastern Time. The fireside chat and Q&A will be webcast live on the company’s investor relations website, with an archived replay available within 24 hours and accessible until October 12, 2026, according to Quest Diagnostics.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECAUCUS, N.J., Aug. 24, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President & Chief Financial Officer, will speak on the company's strategy, performance and the latest market developments and trends during the Morgan Stanley 24th Annual Global Healthcare Conference in New York City on Monday, September 14, 2026, at 10:00 a.m. Eastern Time.

The fireside chat and Q&A session will be webcast live during the conference on the company's investor relations page, which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until October 12, 2026.

About Quest Diagnostics

Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-morgan-stanley-24th-annual-global-healthcare-conference-302857722.html

SOURCE Quest Diagnostics

FAQ

When will Quest Diagnostics (DGX) present at the Morgan Stanley Global Healthcare Conference 2026?

Quest Diagnostics will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026, at 10:00 a.m. Eastern Time. According to Quest Diagnostics, Executive Vice President & CFO Sam Samad will speak on strategy, performance and current healthcare market trends.

Who is speaking for Quest Diagnostics (NYSE: DGX) at the Morgan Stanley 24th Annual Global Healthcare Conference?

Executive Vice President & Chief Financial Officer Sam Samad will represent Quest Diagnostics at the Morgan Stanley 24th Annual Global Healthcare Conference. According to Quest Diagnostics, he will discuss the company’s strategy, performance, and recent market developments during a fireside chat and Q&A session.

How can investors access the Quest Diagnostics (DGX) webcast for the September 14, 2026 Morgan Stanley conference?

Investors can access the live Quest Diagnostics webcast via the company’s investor relations page at ir.QuestDiagnostics.com. According to Quest Diagnostics, the fireside chat and Q&A session will be streamed live there during the Morgan Stanley conference in New York City.

Will a replay of the Quest Diagnostics (DGX) Morgan Stanley 2026 conference presentation be available?

Yes, a replay will be available. According to Quest Diagnostics, the archived webcast will be posted within 24 hours after the live event and remain accessible on the investor relations website until October 12, 2026 for on-demand viewing.

What topics will Quest Diagnostics (DGX) cover at the Morgan Stanley Global Healthcare Conference on September 14, 2026?

Quest Diagnostics plans to cover its strategy, performance and the latest market developments and trends. According to Quest Diagnostics, CFO Sam Samad will address these topics during a fireside chat and Q&A session at the Morgan Stanley 24th Annual Global Healthcare Conference.